ASPIRIN INHIBITS THE EARLY MYOCARDIAL RELEASE OF THROMBOXANE B2 AND VENTRICULAR ECTOPIC ACTIVITY FOLLOWING ACUTE CORONARY ARTERY OCCLUSION IN DOGS

ASPIRIN INHIBITS THE EARLY MYOCARDIAL RELEASE OF THROMBOXANE B2 AND VENTRICULAR ECTOPIC ACTIVITY FOLLOWING ACUTE CORONARY ARTERY OCCLUSION IN DOGS

Acute coronary artery occlusion in anaesthetized open‐chest greyhounds led to early release of thromboxane B2 (TxB2) into venous blood draining the ischaemic region. No release occurred from the remainder of the left ventricular wall (coronary sinus sampling). TxB2 release and ventricular ectopic ac...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:British journal of pharmacology 1981-04, Vol.72 (4), p.593-595
Hauptverfasser: COKER, SUSAN J., LEDINGHAM, I. McA, PARRATT, J.R., ZEITLIN, I.J.
Format: Artikel
Sprache:eng
Schlagworte:
Animals
Arrhythmias, Cardiac - etiology
Arrhythmias, Cardiac - prevention & control
Aspirin - pharmacology
Coronary Disease - complications
Coronary Disease - metabolism
Dogs
Myocardium - metabolism
Thromboxane B2 - metabolism
Thromboxanes - metabolism
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Acute coronary artery occlusion in anaesthetized open‐chest greyhounds led to early release of thromboxane B2 (TxB2) into venous blood draining the ischaemic region. No release occurred from the remainder of the left ventricular wall (coronary sinus sampling). TxB2 release and ventricular ectopic activity were positively correlated (r = 0.863) 2 min post‐occlusion. Aspirin (3 mg/kg i.v.) suppressed both local TxB2 release and ectopic activity and prevented ventricular fibrillation. It is suggested that TxB2 release is a factor contributing to early post‐infarction arrhythmias.
ISSN:0007-1188
1476-5381
DOI:10.1111/j.1476-5381.1981.tb09138.x